Navigation Links
Old flu drugs not effective against seasonal influenza

Researcher Tom Jefferson and colleagues from Cochrane Collaboration (International private organization which reports review from compiling data from various clinical trials) reviewed data from over 50 clinical trials involving influenza symptoms and treatment. //

The researchers found that the old drugs which were used against influenza were not found to be effective now, some drugs like amantadine and rimantidine which were used to control symptoms and kill influenza was not found to be effective against present flu virus strains and they don’t have any effect against them but only lead to side effects of the drug.

The researchers also said that the new antiflu drugs which were said to be useful against influenza symptoms apart from bird flu infection was also not very useful in treating the influenza disease. The new drugs Tamiflu and Relenza would only be helpful in treating severe pandemic diseases of bird flu in humans and would not have any effective against the seasonal influenza virus infection.

The pharmaceutical manufacturers of Relenza and Tamiflu were not happy with the review results and has said that the results are not very encouraging as they feel in their trial on humans they found both these drugs Relenza and Tamiflu were very effective in controlling seasonal influenza infection besides bird flu infection.

Cochrane Review has done this review from collecting data from research done for the past 40 years in the field of influenza diseases and their symptoms and the review committee has published their review in the Lancet.


'"/>




Page: 1

Related medicine news :

1. Cancer drugs in development nearly doubled since 1995
2. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
3. African HIV strains more resistant to anti HIV drugs
4. Right drugs drastically cut stroke risk
5. Relating heart protection and antihypertensive drugs
6. Enzyme may be target for obesity drugs
7. New HIV cases resist drugs
8. Relief to pregnant women using fertility drugs
9. AIDS drugs linked to heart attack risk
10. FDA debates status of decongestant drugs
11. Status of some prescription drugs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/8/2016)... , ... December 08, 2016 , ... ... offering Medication Therapy Management (MTM), adherence, and other pharmacist-delivered patient care services, has ... general counsel and Eric Hoessel to vice president of sales. , Litsinger ...
(Date:12/8/2016)... (PRWEB) , ... December 08, 2016 , ... With the ... created the “What’s In Your Mouth?” (WIYM) campaign to inform dentists and patients about ... Dentistry, the dental implant and prosthetic market in the U.S. is projected to reach ...
(Date:12/8/2016)... , ... December 08, 2016 , ... Premier Fitness Camp ... FIT , the ultimate weight loss and wellness program, at their world headquarters of ... to provide immediate and long-term results to anyone seeking weight loss, personal development, a ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... development continuity to its innovative Unified Instance Manager architecture, meeting the needs ... this new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
Breaking Medicine News(10 mins):
(Date:12/9/2016)...  Axovant Sciences Ltd. (NYSE: AXON ... the treatment of dementia, today announced a new ... trial evaluating treatment with intepirdine (RVT-101), combined with ... placebo in people with mild-to-moderate Alzheimer,s disease. This ... treatment was associated with reduced progression in dependence ...
(Date:12/8/2016)... Calif. , Dec. 8, 2016 IRIDEX Corporation ... to offer newly issued shares of common stock, $0.01 par ... to an underwritten public offering.  The final terms of the ... time of pricing, and there can be no assurance as ... IRIDEX expects to use the net proceeds it will ...
(Date:12/8/2016)... 8, 2016 Australia Glaucoma Surgery Devices ... new report, "Australia Glaucoma Surgery Devices Market Outlook ... Australia Glaucoma Surgery Devices market. The report provides ... units) and average prices (USD) within market segement ... provides company shares and distribution shares data for ...
Breaking Medicine Technology: